[go: up one dir, main page]

MX2018002926A - Composiciones contra alergia a los gatos. - Google Patents

Composiciones contra alergia a los gatos.

Info

Publication number
MX2018002926A
MX2018002926A MX2018002926A MX2018002926A MX2018002926A MX 2018002926 A MX2018002926 A MX 2018002926A MX 2018002926 A MX2018002926 A MX 2018002926A MX 2018002926 A MX2018002926 A MX 2018002926A MX 2018002926 A MX2018002926 A MX 2018002926A
Authority
MX
Mexico
Prior art keywords
cat
relates
present
compositions
compositions against
Prior art date
Application number
MX2018002926A
Other languages
English (en)
Inventor
Bachmann Martin
Jennings Gary
KÜNDIG Thomas
SENTI Gabriela
Zabel Franziska
Original Assignee
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Zuerich filed Critical Univ Zuerich
Publication of MX2018002926A publication Critical patent/MX2018002926A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere al uso de una composición en un método para reducir la alergenicidad de un gato. Además, la presente invención se refiere al uso de una composición en un método para reducir la alergenicidad de un gato para un humano expuesto al gato. Además, la presente invención se refiere a composiciones que comprenden una partícula similar a virus (VLP) y al menos una proteína Fel d1. Las composiciones de la invención inducen respuestas inmunitarias eficientes, en particular respuestas de anticuerpos, en gatos y son útiles para el tratamiento y/o la prevención de la alergia a los gatos.
MX2018002926A 2015-09-08 2016-09-07 Composiciones contra alergia a los gatos. MX2018002926A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15184198 2015-09-08
EP15189558 2015-10-13
PCT/EP2016/071125 WO2017042241A1 (en) 2015-09-08 2016-09-07 Compositions against cat allergy

Publications (1)

Publication Number Publication Date
MX2018002926A true MX2018002926A (es) 2019-01-30

Family

ID=56997460

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018002926A MX2018002926A (es) 2015-09-08 2016-09-07 Composiciones contra alergia a los gatos.

Country Status (14)

Country Link
US (2) US10835600B2 (es)
EP (1) EP3347046B1 (es)
JP (1) JP6876682B2 (es)
KR (1) KR102812106B1 (es)
CN (1) CN108025059B (es)
AU (1) AU2016319075B2 (es)
CA (1) CA2995003A1 (es)
CO (1) CO2018002207A2 (es)
HK (1) HK1255206A1 (es)
MX (1) MX2018002926A (es)
NZ (1) NZ740816A (es)
RU (1) RU2018105007A (es)
WO (1) WO2017042241A1 (es)
ZA (1) ZA201800821B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA40824A (fr) * 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
IL319030A (en) 2018-12-20 2025-04-01 Saiba AG CMV virus-like particles modified by fusion
KR102427400B1 (ko) 2020-09-21 2022-08-02 농업회사법인 (주)더킹콩 알러지 주요유전자 Fel d 1 타켓 고양이 셀라인 구축
CN114437211B (zh) * 2022-01-26 2024-03-12 南京麦西崴克生物科技有限公司 基于猫过敏原Fel d1的卵黄抗体的制备方法
CN114487439B (zh) * 2022-01-26 2024-12-13 南京麦西崴克生物科技有限公司 猫过敏原Fel d1卵黄抗体的间接ELISA方法
CN117004650B (zh) * 2023-06-25 2024-05-14 山东立菲生物产业有限公司 一种猫皮屑过敏原组分feld1双链二聚体重组蛋白、制备方法及应用
WO2025255685A1 (en) * 2024-06-14 2025-12-18 Angany Inc. Bioparticles for the expression of multimeric proteins
CN119409839B (zh) * 2025-01-06 2025-03-11 南京农业大学三亚研究院 一种Fel D1与Fel D4融合蛋白及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3738395B2 (ja) * 1991-08-26 2006-01-25 エピミューン，インコーポレイティド Ｈｌａ−制限型ｂ型肝炎ウィルスのｃｔｌエピトープ
AU706875B2 (en) * 1994-12-30 1999-06-24 Seminis Vegetable Seeds, Inc. Plants resistant to C strains of cucumber mosaic virus
US20060088909A1 (en) * 2002-05-17 2006-04-27 Compans Richard W Virus-like particles, methods of preparation, and immunogenic compositions
CN102061288A (zh) * 2002-07-17 2011-05-18 希托斯生物技术股份公司 使用衍生自ap205外壳蛋白的病毒样颗粒的分子抗原阵列
NZ561040A (en) * 2005-03-18 2009-04-30 Cytos Biotechnology Ag Cat allergen fusion proteins and use thereof
WO2007068747A1 (en) * 2005-12-14 2007-06-21 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
CN100374152C (zh) * 2005-12-23 2008-03-12 中国农业大学 一种过敏性反应抑制剂
WO2007113633A2 (en) 2006-04-03 2007-10-11 Pfizer Products Inc. Immunogenic compositions comprising cat allergen fel dl
JO3820B1 (ar) * 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها

Also Published As

Publication number Publication date
KR102812106B1 (ko) 2025-05-22
ZA201800821B (en) 2018-12-19
CA2995003A1 (en) 2017-03-16
CO2018002207A2 (es) 2018-11-22
AU2016319075A1 (en) 2018-04-12
US10835600B2 (en) 2020-11-17
AU2016319075B2 (en) 2022-09-22
RU2018105007A3 (es) 2020-01-31
KR20180049061A (ko) 2018-05-10
EP3347046B1 (en) 2022-10-19
JP6876682B2 (ja) 2021-05-26
US20210106676A1 (en) 2021-04-15
EP3347046A1 (en) 2018-07-18
CN108025059B (zh) 2022-09-09
CN108025059A (zh) 2018-05-11
US11571474B2 (en) 2023-02-07
WO2017042241A1 (en) 2017-03-16
HK1255206A1 (zh) 2019-08-09
RU2018105007A (ru) 2019-10-10
US20180250387A1 (en) 2018-09-06
NZ740816A (en) 2022-05-27
JP2018537401A (ja) 2018-12-20

Similar Documents

Publication Publication Date Title
MX2018002926A (es) Composiciones contra alergia a los gatos.
WO2016004389A3 (en) Monovalent binding proteins
MX2022007522A (es) Anticuerpos anti-cd27.
MX2022001105A (es) Anticuerpos anti tigit.
MX2022003891A (es) Anticuerpos anti-muc16 y sus usos.
MX2022004072A (es) Anticuerpos de factor xi y metodos de uso.
PH12016501644A1 (en) Binding proteins and methods of use thereof
MY174991A (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
PH12017500450A1 (en) Flavivirus virus like particle
MX2022002635A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
PH12017500304A1 (en) Vaccine compositions against dengue virus diseases
WO2017029558A3 (en) Methods for improving health of farmed fish
TW201613628A (en) Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
MX2022009171A (es) Composiciones para el tratamiento de dermatitis atopica canina y sus usos.
MX2016001223A (es) Metodo para el pronostico de la eficacia de la inmunoterapia oral para el tratamiento de la alergia a las proteinas de leche de vaca.
NZ728041A (en) Substances and methods for the use in prevention and/or treatment in huntington’s disease
EP3131545C0 (en) USE OF ENOXIMONE FOR THE TREATMENT OF TOPICAL CONDITIONS ASSOCIATED WITH THE IMMUNE SYSTEM, IN PHARMACEUTICAL COMPOSITIONS AS WELL AS IN PHARMACEUTICAL PREPARATIONS